Skip to content

Comparison of the effect of intra-articular hypertonic saline, intra-articular HIALGAN and physiotherapy in patients with knee arthritis

Comparisonof the effectiveness of intra-articular injection of hypertonic saline, intra-articular injection of HIALGAN and knee physiotherapy in pain and function of patients with knee osteoarthritis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190309042989N1
Enrollment
90
Registered
2019-04-19
Start date
2019-05-05
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis. Osteoarthritis of knee

Interventions

Intervention 1: First intervention group: Intra-articular injection of 5cc from Hypertonic Saline solution 5%(solution with a concentration of sodium chloride) at one time .Hypersalin brand medication

Sponsors

Artesh University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: ACR criteria (age more than 50 years old / cryptasion or morning stiffness less than 30 minutes / presence of radiographic evidence / presence of symptoms for more than three months) K-L radiographic criteria : grade 2-4

Exclusion criteria

Exclusion criteria: Patient dissatisfaction Other joint arthritis in the knee joint including rheumatoid arthritis and gout or systemic neuromuscular disorders such as Myasthenia Gravis, Eton-Lambert syndrome and ALS. History of total Knee arthroplasty History of fracture in the knee bones Intra-articular corticosteroid injection over the past 2 weeks, history of hyaluronic acid injection or proletherapy over the past one year Any contraindication for intra-articular injection such as thrombocytopenia , coagulation disorder, joint infections, skin infections at the injection site Dysfunction of the lower extremity due to neurological or internal diseases such as stroke, traumatic brain injury, and diabetic foot disease Severe knee joint effusion BM I> 35 Acute exacerbation of knee pain (less than 1 month)

Design outcomes

Primary

MeasureTime frame
Pain intensity based on the Visual Analogue Scale. Timepoint: Measuring pain intensity before the intervention, 1 month, 3 months and 6 months after the end of the intervention. Method of measurement: Visual Analogue Scale.

Secondary

MeasureTime frame
Symptoms. Timepoint: Before the intervention, 1 month, 3 months and 6 months after the end of the intervention. Method of measurement: Knee injury and Osteoarthritis Outcome Score (KOOS).;Pain. Timepoint: Before the intervention, 1 month, 3 months and 6 months after the end of the intervention. Method of measurement: Knee injury and Osteoarthritis Outcome Score (KOOS).;Function, daily living. Timepoint: Before the intervention, 1 month, 3 months and 6 months after the end of the intervention. Method of measurement: Knee injury and Osteoarthritis Outcome Score (KOOS).;Function, sports and recreational activities. Timepoint: Before the intervention, 1 month, 3 months and 6 months after the end of the intervention. Method of measurement: Knee injury and Osteoarthritis Outcome Score (KOOS).;Quality of Life. Timepoint: Before the intervention, 1 month, 3 months and 6 months after the end of the intervention. Method of measurement: Knee injury and Osteoarthritis Outcome Score (KOOS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ensieh Taftian

Artesh University of Medical Sciences

ensieh.taftian@gmail.com+98 21 6653 5399

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026